Leerink Swann & Company Resumes Coverage of Boston Scientific Corporation (NYSE: BSX)
28 9월 2004 - 11:14PM
PR Newswire (US)
Leerink Swann & Company Resumes Coverage of Boston Scientific
Corporation (NYSE: BSX) BOSTON, Sept. 28 /PRNewswire/ -- This
morning, Senior Medical Devices Analyst Jason Wittes resumed
coverage of Boston Scientific Corporation (NYSE: BSX) with a Market
Perform rating. About Boston Scientific Corporation Boston
Scientific is a worldwide developer, manufacturer and marketer of
medical devices. For more than twenty-five years, Boston Scientific
has advanced the practice of less-invasive by providing a broad and
deep portfolio of innovative products, technologies, and services
across a wide-range of medical specialties. Boston Scientific is
based in Natick, Massachusetts. About Leerink Swann & Company
Leerink Swann & Company is an investment banking firm that
provides healthcare equity research, corporate finance, and asset
management services for institutional and high-net-worth clients.
Leerink Swann & Company was voted the Best Firm in
Biotechnology, Health Care Facilities, Medical Supplies and
Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the
December 2003 Institutional Investor poll ranking the best boutique
and regional firms by sector. Through its consulting affiliate,
MEDACorp, Leerink Swann & Company provides
biomedical-consulting services to Life Sciences companies and to
the institutional investment community. MEDACorp is comprised of
11,000 consultants who are practicing physicians, surgeons, and
biomedical professionals. Leerink Swann & Company is a member
NASD/SIPC. Leerink Swann & Company is a member of the National
Association of Securities Dealers, CRD number 39011. Contact: John
I. Fitzgerald Leerink Swann & Company (617) 918-4564
http://www.leerink.com/ DATASOURCE: Leerink Swann & Company
CONTACT: John I. Fitzgerald of Leerink Swann & Company,
+1-617-918-4564 Web site: http://www.leerink.com/
Copyright